WallStSmart

MDB Capital Holdings, LLC Class A common (MDBH)vsMorgan Stanley (MS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Morgan Stanley generates 1772955% more annual revenue ($73.17B vs $4.13M). MS leads profitability with a 24.7% profit margin vs 0.0%. MS earns a higher WallStSmart Score of 71/100 (B).

MDBH

Avoid

23

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 5.0Quality: 8.5
Piotroski: 3/9Altman Z: 10.55

MS

Strong Buy

71

out of 100

Grade: B

Growth: 9.3Profit: 7.5Value: 4.3Quality: 4.0
Piotroski: 5/9Altman Z: 0.38

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDBH3 strengths · Avg: 10.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
10.5510/10

Safe zone — low bankruptcy risk

MS5 strengths · Avg: 9.0/10
Market CapQuality
$339.08B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
40.6%10/10

Strong operational efficiency at 40.6%

Profit MarginProfitability
24.7%9/10

Keeps 25 of every $100 in revenue as profit

Revenue GrowthGrowth
16.3%8/10

16.3% revenue growth

EPS GrowthGrowth
31.9%8/10

Earnings expanding 31.9% YoY

Areas to Watch

MDBH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$36.54M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

MS4 concerns · Avg: 1.8/10
PEG RatioValuation
2.542/10

Expensive relative to growth rate

Free Cash FlowQuality
$-7.85B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.382/10

Distress zone — elevated risk

Debt/EquityHealth
3.451/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : MDBH

The strongest argument for MDBH centers on Price/Book, Debt/Equity, Altman Z-Score.

Bull Case : MS

The strongest argument for MS centers on Market Cap, Operating Margin, Profit Margin. Profitability is solid with margins at 24.7% and operating margin at 40.6%. Revenue growth of 16.3% demonstrates continued momentum.

Bear Case : MDBH

The primary concerns for MDBH are EPS Growth, Market Cap, Profit Margin.

Bear Case : MS

The primary concerns for MS are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 3.45 is elevated, increasing financial risk.

Key Dynamics to Monitor

MDBH profiles as a value stock while MS is a growth play — different risk/reward profiles.

MDBH carries more volatility with a beta of 1.25 — expect wider price swings.

MS is growing revenue faster at 16.3% — sustainability is the question.

MDBH generates stronger free cash flow (-3M), providing more financial flexibility.

Bottom Line

MS scores higher overall (71/100 vs 23/100), backed by strong 24.7% margins and 16.3% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MDB Capital Holdings, LLC Class A common

FINANCIAL SERVICES · CAPITAL MARKETS · USA

MDB Capital Holdings, LLC (MDBH) is a progressive investment firm focused on driving growth in the technology and life sciences sectors through strategic capital allocation and specialized advisory services. With a seasoned management team that possesses deep industry expertise, MDBH is committed to enhancing shareholder value and generating substantial returns for institutional investors by identifying and leveraging emerging opportunities in dynamic markets. As a Class A common stock, MDBH is strategically positioned to thrive amid economic shifts, supporting its mission of fostering innovation and financial integrity while pursuing transformative growth prospects.

Visit Website →

Morgan Stanley

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City.

Want to dig deeper into these stocks?